| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/04/2013 | CN103417732A Pharmaceutical composition for treatment of hyperglycemia |
| 12/04/2013 | CN103417726A Traditional Chinese medicine for treating diabetes |
| 12/04/2013 | CN103417718A Pressure-reduction and fat-eliminating tea |
| 12/04/2013 | CN103417716A Hypoglycemic Tongluo tablet for treating diabetic peripheral neuropathy |
| 12/04/2013 | CN103417713A Traditional Chinese medicine for treating hypoglycemia |
| 12/04/2013 | CN103417694A Traditional Chinese medicine used for treating diabetes |
| 12/04/2013 | CN103417683A Health food capable of reducing blood sugar |
| 12/04/2013 | CN103417670A Medicinal composition for blood fat reduction and antiatherosclerosis, and preparation method thereof |
| 12/04/2013 | CN103417634A Active site of mulberry twig, as well as preparation method and application thereof |
| 12/04/2013 | CN103417633A Chinese herbal medicine |
| 12/04/2013 | CN103417625A Medicine for treating diabetes skin ulcer |
| 12/04/2013 | CN103417624A Health wine for preventing high blood pressure, high cholesterol, high blood sugar, cardiovascular and cerebrovascular diseases and various tumors |
| 12/04/2013 | CN103417613A Compound essence for decreasing blood sugar and extraction process thereof |
| 12/04/2013 | CN103417612A Chinese herbal medicine processed radix puerariae decoction pieces and preparation method thereof |
| 12/04/2013 | CN103417601A Pharmaceutical composition capable of adjusting blood fat and applications thereof |
| 12/04/2013 | CN103417592A Application of ginseng water-insoluble substance to diabetes and obesity prevention and treatment |
| 12/04/2013 | CN103417588A Preparation method of effective part of Hippophae rhamnoides |
| 12/04/2013 | CN103417583A Auricularia polytricha extractive and a preparation method and application thereof |
| 12/04/2013 | CN103417581A Medicine composition for wound therapy |
| 12/04/2013 | CN103417578A Preparation for adjusting abnormal cholesterol |
| 12/04/2013 | CN103417524A Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 12/04/2013 | CN103417523A Application of L-glutamine to preparation of drug for treating high homocysteine |
| 12/04/2013 | CN103417520A Combined calcium preparation |
| 12/04/2013 | CN103417496A Method for preparing metformin hydrochloride controlled-release pellet preparation |
| 12/04/2013 | CN103417495A Method for preparing pioglitazone hydrochloride controlled-release pellet preparation slow-release layer |
| 12/04/2013 | CN103417489A Calcium gluconate zinc gluconate particulate agent preparation method |
| 12/04/2013 | CN103416746A Lipid-lowing selenium-rich tea pigment and production method thereof |
| 12/04/2013 | CN103416598A Preparation method of micro-encapsulation coated yolk derived cholecystokinin antibodies |
| 12/04/2013 | CN103416559A Dendrobium nobile tea and preparation method thereof |
| 12/04/2013 | CN103416312A Plants as functional siRNA vehicles and preparation methods and uses thereof |
| 12/04/2013 | CN103416311A Plants as functional microRNA vehicles and preparation methods and uses thereof |
| 12/04/2013 | CN103110626B Pharmaceutical composition and application thereof |
| 12/04/2013 | CN102805818B Hypoglycemic drug and preparation method thereof |
| 12/04/2013 | CN102697781B Application of trigonelline in preparation of medicament for preventing and treating diabetes and complication thereof |
| 12/04/2013 | CN102670917B Composite enzyme and its preparation method |
| 12/04/2013 | CN102631521B Method for extracting dioscin by utilizing two-aqueous-phase system |
| 12/04/2013 | CN102600149B Pharmaceutical composition for treating diabetes |
| 12/04/2013 | CN102579713B Traditional Chinese medicine for treating children obesity and preparation method |
| 12/04/2013 | CN102552479B Chinese herbal medicine composition for treating diabetic foot |
| 12/04/2013 | CN102512518B Chinese medicinal extract for treating diabetic peripheral neuropathy and preparation method thereof |
| 12/04/2013 | CN102462826B Chinese medicinal composition for reducing blood lipids and preparation method and application thereof |
| 12/04/2013 | CN102462738B Traditional Chinese medicine composition having effects of reducing blood sugar and resisting oxidation, and preparation method thereof |
| 12/04/2013 | CN102427807B Anti-obesity agent comprising compound containing benzotropolone ring |
| 12/04/2013 | CN102424818B Caspase-1-ES cell line induced by mifepristone |
| 12/04/2013 | CN102366541B Traditional Chinese medicine composition for treatment of diabetes |
| 12/04/2013 | CN102327309B Barberry bark extractive and use of barberry bark extractive and barberry bark |
| 12/04/2013 | CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones |
| 12/04/2013 | CN102242079B Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof |
| 12/04/2013 | CN102170876B Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient |
| 12/04/2013 | CN102159586B C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 12/04/2013 | CN101925603B Modulators of cystic fibrosis transmembrane conductance regulator |
| 12/04/2013 | CN101909610B Composition for oral administration |
| 12/04/2013 | CN101622231B 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 12/04/2013 | CN101505776B Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
| 12/03/2013 | US8598360 Apoptosis signal-regulating kinase inhibitors |
| 12/03/2013 | US8598324 Anti-pathogen treatments |
| 12/03/2013 | US8598160 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/03/2013 | US8598146 Methods for identifying modulators of protein kinase C-epsilon (PKCε) and method of treatment of aberrant glucose metabolism associated therewith |
| 12/03/2013 | US8598120 Methods for treatment using amylin family peptides |
| 12/03/2013 | CA2611529C Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 12/03/2013 | CA2539446C 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/03/2013 | CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 12/03/2013 | CA2449426C Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013177588A1 C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS |
| 11/28/2013 | WO2013177565A1 Insulin-pramlintide compositions and methods for making and using them |
| 11/28/2013 | WO2013177458A1 Compositions for increasing strength, muscle mass, and lean body mass |
| 11/28/2013 | WO2013177432A1 Methods of treating obesity |
| 11/28/2013 | WO2013177053A1 Pyrimidino [1, 2 -c] quinazolinone derivatives as tyrosine kinases inhibitors |
| 11/28/2013 | WO2013176564A1 Terpenoid agent for the prophylaxis and treatment of atherosclerosis and the correction of metabolic syndrome |
| 11/28/2013 | WO2013176220A1 Regulation of circadian rhythm |
| 11/28/2013 | WO2013175415A1 Substituted pyrimidine compounds and uses thereof |
| 11/28/2013 | WO2013175386A1 Compositions and methods for increasing strength and muscle mass |
| 11/28/2013 | WO2013175297A1 Salts of saxagliptin with organic acids |
| 11/28/2013 | WO2013174768A1 A xanthine derivative as dpp -4 inhibitor for use in the treatment of autoimmune diabetes, particularly lada |
| 11/28/2013 | WO2013174767A1 A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| 11/28/2013 | WO2013174485A1 SUBSTITUTED ß-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS |
| 11/28/2013 | WO2013174207A1 Protein tyrosine phosphatase inhibitor, preparation method and uses thereof |
| 11/28/2013 | WO2013174133A1 Application of sbt in preventing and treating diabetes mellitus vasculopathy and neuropathy |
| 11/28/2013 | WO2013173972A1 Fructus ligustri lucidi for growth in children |
| 11/28/2013 | WO2013173923A1 Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| 11/28/2013 | WO2013173858A1 A method of weight reduction |
| 11/28/2013 | WO2013038429A3 Novel sglt inhibitors |
| 11/28/2013 | US20130317047 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 11/28/2013 | US20130317013 Ep4 receptor agonist, compositions and methods thereof |
| 11/28/2013 | US20130315904 Combinations of modalities for the treatment of diabetes |
| 11/27/2013 | EP2666769A1 Substituted B-amino acid derivatives as CXCR3 receptor antagonist |
| 11/27/2013 | EP2666764A1 Ferric citrate containing substantially no -oxidized iron hydroxide |
| 11/27/2013 | EP2666761A1 Hydroxytyrosol ethers |
| 11/27/2013 | EP2666358A1 Treating Psychological Conditions Using Muscarinic Receptor M1 Antagonists |
| 11/27/2013 | EP2665814A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
| 11/27/2013 | EP2665732A1 Fused aminodihydrothiazine derivatives useful as bace inhibitors |
| 11/27/2013 | EP2665729A1 Piperazine derivatives as cav2.2 calcium channel blockers |
| 11/27/2013 | EP2665728A2 Preparation method of intermediate of sitagliptin |
| 11/27/2013 | EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders |
| 11/27/2013 | EP2665713A1 1,4 oxazines as bace1 and/or bace2 inhibitors |
| 11/27/2013 | EP2665707A1 Mineralocorticoid receptor antagonists |
| 11/27/2013 | EP2665487A1 Combination of acylated glucagon analogues with insulin analogues |
| 11/27/2013 | EP2665486A1 Compositions and mehthods for modulating gamma-c-cytokine activity |
| 11/27/2013 | EP2665485A1 Apolipoprotein aiv as an antidiabetic peptide |